Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Next Previous
X
Search
Trial Profile

Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Aug 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Perampanel (Primary)
  • Indications Generalised seizures; Partial epilepsies; Seizures; Tonic-clonic epilepsy
  • Focus Therapeutic Use
  • Acronyms ELEVATE
  • Sponsors Eisai Inc

    • Most Recent Events

    • 14 Aug 2023 According to a Catalyst Pharmaceuticals media release, results from this study will be presented at the upcoming 35th International Epilepsy Congress taking place on September 2 - 6, 2023 in Dublin, Ireland
    • 27 Apr 2023 Results assessing change in baseline in cognition scores, efficacy, and safety in a subgroup of patients with a history of psychiatric and behavioral events, presented at the 75th Annual Meeting of the American Academy of Neurology 2023.
    • 20 Apr 2023 According to a Catalyst Pharmaceuticals media release, data from this study (to be presented in AAN 2023) is presented online https://index.mirasmart.com/aan2023/PDFfiles/AAN2023-002293.html.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top